Literature DB >> 2969982

Expression of interferon-induced genes in different tissues of mice.

A M Flenniken1, J Galabru, M N Rutherford, A G Hovanessian, B R Williams.   

Abstract

In vivo responses to interferon (IFN) in mice were determined by measuring the steady-state levels of induced mRNAs following injection of IFN and poly(I)-poly(C). With cDNA probes for mouse 2'-5' oligoadenylate synthetase (2-5A synthetase) and 1-8, constitutive expression of the corresponding mRNA was detectable in different organs of normal C3H/He mice. These mRNA levels were increased by as much as 15-fold over control levels in various tissues, including the brain, after IFN and poly(I)-poly(C) treatment, coincident with increases in 2-5A synthetase enzyme activity. The basal activity level of this enzyme could be reduced in normal mice by treatment with anti-mouse IFN (alpha + beta) antibody. This treatment also reduced the levels of 2-5A synthetase and 1-8 mRNAs. Thus, physiological levels of circulating IFN maintain elevated levels of IFN-induced mRNAs in mice. Furthermore, changes in 2-5A synthetase enzyme activity reflect the changes in gene expression in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969982      PMCID: PMC253423     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Production and role of interferon in physiological conditions.

Authors:  V Bocci
Journal:  Biol Rev Camb Philos Soc       Date:  1981-02

2.  Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases.

Authors:  C Buffet-Janvresse; H Magard; N Robert; A G Hovanessian
Journal:  Ann Immunol (Paris)       Date:  1983 Sep-Oct

3.  Analysis of interferon mRNA in human fibroblast cells induced to produce interferon.

Authors:  N B Raj; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

4.  p67K kinase in different tissues and plasma of control and interferon-treated mice.

Authors:  B Krust; Y Rivière; A G Hovanessian
Journal:  Virology       Date:  1982-07-15       Impact factor: 3.616

5.  Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells.

Authors:  R L Friedman; S P Manly; M McMahon; I M Kerr; G R Stark
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

6.  Structure and expression of a cloned cDNA for mouse interferon-beta.

Authors:  Y Higashi; Y Sokawa; Y Watanabe; Y Kawade; S Ohno; C Takaoka; T Taniguchi
Journal:  J Biol Chem       Date:  1983-08-10       Impact factor: 5.157

7.  Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

Authors:  M J Clemens; B R Williams
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

8.  Interferon messenger RNA is produced constitutively in the organs of normal individuals.

Authors:  M G Tovey; M Streuli; I Gresser; J Gugenheim; B Blanchard; J Guymarho; F Vignaux; M Gigou
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Enhancement of natural killer cell activity and 2-5A synthetase in mice treated with polyadenylic.polyuridylic acid.

Authors:  J K Youn; A G Hovanessian; Y Riviere; G Hue; F Lacour
Journal:  Cell Immunol       Date:  1983-07-15       Impact factor: 4.868

10.  Assay of interferon-mediated protein kinase activity from plasma and tissue extracts.

Authors:  A G Hovanessian; Y Rivière; B Krust
Journal:  Anal Biochem       Date:  1983-03       Impact factor: 3.365

View more
  8 in total

1.  Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis.

Authors:  K Sandberg; M L Eloranta; I L Campbell
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 2.  Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.

Authors:  D E Goodkin
Journal:  West J Med       Date:  1994-09

3.  Prescribing recommendations for interferon-Beta in multiple sclerosis.

Authors:  B Weinstock-Guttman; R A Rudick
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

4.  Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.

Authors:  Hongyan Wang; Animesh Ghosh; Huricha Baigude; Chao-Shun Yang; Linghua Qiu; Xugang Xia; Hongxia Zhou; Tariq M Rana; Zuoshang Xu
Journal:  J Biol Chem       Date:  2008-03-26       Impact factor: 5.157

Review 5.  From bats to pangolins: new insights into species differences in the structure and function of the immune system.

Authors:  Patrick J Haley
Journal:  Innate Immun       Date:  2022-05-04       Impact factor: 2.951

6.  Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes.

Authors:  L F Reis; H Ruffner; G Stark; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

7.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

8.  A Single Amino Acid in the Polymerase Acidic Protein Determines the Pathogenicity of Influenza B Viruses.

Authors:  Joon-Yong Bae; Ilseob Lee; Jin Il Kim; Sehee Park; Kirim Yoo; Miso Park; Gayeong Kim; Mee Sook Park; Joo-Yeon Lee; Chun Kang; Kisoon Kim; Man-Seong Park
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.